Soy-based S-equol lowers HbA1c, LDL cholesterol and improves vascular stiffness

[News]

A 12-week treatment of the fermented soy germ-based nutritional supplement containing S-equol significantly lowered hemoglobin A1c (HbA1c), LDL cholesterol and improved vascular stiffness, all factors that occur as part of metabolic syndrome, according to a first-of-its-kind peer-reviewed study reported in a poster at the Women's Health 2012 annual meeting.

More... (http://www.news-medical.net/news/20120319/Soy-based-S-equol-lowers-HbA1c-LDL-cholesterol-and-improves-vascular-stiffness.aspx)